Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival

Gouin, F., Ory, B., Redini, F. et al. (1 more author) (2006) Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival. International Journal of Cancer, 119 (5). pp. 980-984. ISSN 0020-7136

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2006 Wiley-Liss, Inc.
Keywords: bisphosphonate; chondrosarcoma; therapy; primary bone tumors; adjuvant treatment
Dates:
  • Published: 1 September 2006
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 14 Apr 2016 14:32
Last Modified: 07 May 2016 19:23
Published Version: http://dx.doi.org/10.1002/ijc.21951
Status: Published
Publisher: John Wiley & Sons
Identification Number: https://doi.org/10.1002/ijc.21951
Related URLs:

Download

Share / Export

Statistics